$CSTL CASTLE BIOSCIENCES INC Insider Trading
Get free email notifications about insider trading in CASTLE BIOSCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CASTLE BIOSCIENCES INC. Insider overview, share value development, latest insider transactions and email notifications about new events in CASTLE BIOSCIENCES INC for free.
IRS Number: 770701774
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Trading Symbol: CSTL
Company Address: 505 S FRIENDSWOOD DRIVE SUITE 401 FRIENDSWOOD 77546
Phone number: 866-788-9007
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
CASTLE BIOSCIENCES INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | CSTL | CASTLE BIOSCIENCES ... | Aspinall Mara G. | Director | Option Exercise | A | 0.00 | 830 | 0 | 830 | |
| Jun 14 2021 | CSTL | CASTLE BIOSCIENCES ... | Aspinall Mara G. | Director | Option Exercise | A | 71.22 | 3,379 | 240,652 | 3,379 | |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 74.12 | 400 | 29,646 | 506,018 | 506.4 K to 506 K (-0.08 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 72.84 | 2,384 | 173,643 | 506,418 | 508.8 K to 506.4 K (-0.47 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 71.71 | 3,830 | 274,657 | 508,802 | 512.6 K to 508.8 K (-0.75 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 70.92 | 3,386 | 240,128 | 512,632 | 516 K to 512.6 K (-0.66 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 72.84 | 2,554 | 186,041 | 516,018 | 518.6 K to 516 K (-0.49 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 71.47 | 1,695 | 121,137 | 518,572 | 520.3 K to 518.6 K (-0.33 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 70.48 | 1,469 | 103,532 | 520,267 | 521.7 K to 520.3 K (-0.28 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 69.20 | 700 | 48,443 | 521,736 | 522.4 K to 521.7 K (-0.13 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 68.22 | 1,468 | 100,147 | 522,436 | 523.9 K to 522.4 K (-0.28 %) |
| Jun 10 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 67.42 | 2,114 | 142,522 | 523,904 | 526 K to 523.9 K (-0.40 %) |
| Jun 01 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 61.27 | 4,648 | 284,778 | 528,456 | 533.1 K to 528.5 K (-0.87 %) |
| Jun 01 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 60.25 | 4,849 | 292,138 | 533,104 | 538 K to 533.1 K (-0.90 %) |
| Jun 01 2021 | CSTL | CASTLE BIOSCIENCES ... | MAETZOLD DEREK J | Pres. & Chief Exec. ... | Sell | S | 59.04 | 2,536 | 149,725 | 537,953 | 540.5 K to 538 K (-0.47 %) |